The rapid increase in the use of glucagon-like peptide-1 receptor agonists for weight loss, diabetes management and ...

Recent consumer research by product development group AMC Global and OpinionRoute, LLC reveals the evolving preferences of ...

If you’re taking a GLP-1 medication, such as semaglutide (Ozempic or Wegovy), exercise is an essential part of your routine — and not just for weight loss reasons. “Exercise helps you maintain muscle ...

2019). These findings suggest that GLP-1 agonists may reduce the rewarding properties of alcohol and attenuate cravings. Unlike some existing medications that primarily target single ...

Drugs like Ozempic ... Type 2 diabetes to assess the association among glucagon-like peptide-1 receptor agonists, or GLP-1RAs, sodium-glucose cotransporter-2 inhibitors, or SGLT2is, and the ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have ... among glucagon-like peptide-1 receptor agonists, ...

An oral version of these drugs—which are known as glucagon-like peptide 1 (GLP-1) receptor agonists—could be more accessible and would come without the inconvenience, pain or medical waste of ...

If you are taking a weight loss medication such as Ozempic, Wegovy, or Zepbound for obesity or other health concerns, you may ...

Weight loss medications like Wegovy and Zepbound offer powerful tools in the fight against obesity—but they’re not magic bullets. As Dr. Abby emphasizes, lasting success depends on a ...